Finorga
France Updated 9 July 2026
Finorga is an API manufacturer based in France. It holds 3 active US drug master files across a filed portfolio of 4 molecules. Its GMP standing is certified by ANSM (FR) and US FDA. Its most recent recorded inspection, by US FDA, closed on 27 February 2025 as VAI.
4
registered plants
2 with an FDA FEI number
1
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 27 February 2025 VAI US FDA
- 24 November 2023 VAI US FDA
- 20 September 2019 NAI US FDA
- 22 June 2018 NAI US FDA
- 23 September 2016 NAI US FDA
- 30 May 2014 NAI US FDA
- 13 December 2013 VAI US FDA
- 2 June 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| France, France | 3002806990 |
| Mourenx, France | Not on file |
| Chasse Sur Rhone, France | Not on file |
| France, France | 3002806998 |
What they file, and where
| Molecule | Regulators | Docs |
| Adapalene | SFDA (Saudi Arabia), US FDA | 2 |
| Esmolol | SFDA (Saudi Arabia), US FDA | 2 |
| Alizapride Hci | SFDA (Saudi Arabia) | 1 |
| Icosapent Ethyl | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MINSA (CR) | 1 | None |
| ANSM (FR) | None | 38 |
| US FDA | None | 2 |
Comparing suppliers?
Choose your molecules and target markets. Finorga comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- 5 active litigation matters are on record.
- The most recent inspection outcome was VAI, on 27 February 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates